Beryl Drugs Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Sanjay Sethi

Chief executive officer

₹2.1m

Total compensation

CEO salary percentagen/a
CEO tenure24yrs
CEO ownership17.7%
Management average tenureno data
Board average tenure14.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sanjay Sethi's remuneration changed compared to Beryl Drugs's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹3m

Jun 30 2024n/an/a

₹6m

Mar 31 2024₹2mn/a

₹8m

Dec 31 2023n/an/a

₹12m

Sep 30 2023n/an/a

₹10m

Jun 30 2023n/an/a

₹11m

Mar 31 2023₹2mn/a

₹8m

Dec 31 2022n/an/a

₹2m

Sep 30 2022n/an/a

-₹162k

Jun 30 2022n/an/a

-₹8m

Mar 31 2022₹2mn/a

-₹7m

Dec 31 2021n/an/a

-₹674k

Sep 30 2021n/an/a

-₹1m

Jun 30 2021n/an/a

₹8m

Mar 31 2021₹2mn/a

₹2m

Dec 31 2020n/an/a

-₹4m

Sep 30 2020n/an/a

-₹2m

Jun 30 2020n/an/a

-₹5m

Mar 31 2020₹1m₹1m

₹479k

Dec 31 2019n/an/a

₹7m

Sep 30 2019n/an/a

₹8m

Jun 30 2019n/an/a

₹7m

Mar 31 2019₹780k₹780k

₹6m

Dec 31 2018n/an/a

₹8m

Sep 30 2018n/an/a

₹7m

Jun 30 2018n/an/a

₹11m

Mar 31 2018₹780k₹780k

₹10m

Compensation vs Market: Sanjay's total compensation ($USD24.56K) is below average for companies of similar size in the Indian market ($USD42.22K).

Compensation vs Earnings: Sanjay's compensation has been consistent with company performance over the past year.


CEO

Sanjay Sethi (61 yo)

24yrs

Tenure

₹2,100,000

Compensation

Mr. Sanjay Sethi serves as the Managing Director and Executive Director of Beryl Drugs Ltd. and was its Director since December 12, 2000. He Joined Beryl Drugs Limited in December 12, 2000.Mr. Sethi was t...


Board Members

NamePositionTenureCompensationOwnership
Sanjay Sethi
MD & Executive Director24yrs₹2.10m17.74%
₹ 33.1m
Sudhir Sethi
Non Executive Chairman24yrsno data8.65%
₹ 16.1m
Shreya Saraf
Independent Non-Executive Women Director5.6yrs₹35.00kno data
Abhinav Naik
Independent Non-Executive Director5.6yrs₹35.00kno data

14.8yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 524606's board of directors are seasoned and experienced ( 14.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 16:05
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beryl Drugs Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution